Valvular & structural heart disease
Registries on Transcatheter Edge-To-Edge Repair in Heart Failure: Current Evidence and Future Perspectives
Authors' conclusion
Registries on TEER represent a key data source in a setting where it is difficult to conduct randomized controlled trials. However, limitations in design, patient characterization, and outcomes reporting restrain their use.
Study context
- Population
- Patients with heart failure (HF) receiving transcatheter edge-to-edge repair (TEER) for secondary mitral or tricuspid regurgitation26 + 6 registries
- Participants
- 18,925 vs 1,412
- Comparison
- TEER in secondary mitral regurgitation (SMR) vs TEER for tricuspid regurgitation (TR)
- TEER in SMRn = 18,925
- TEER for TRn = 1,412
Methodological detailsPubMed, Web of Science and EMBASE searched
- PubMed, Web of Science and EMBASE searched
Pooled result
As reported in the abstract
Registries retrieved
SMR: 26 registries (46% prospective, 12% ongoing), total cohort
18 925
TR: 6 registries (50% retrospective, 33% ongoing), total cohort
1412
Original publication
Registries on Transcatheter Edge-To-Edge Repair in Heart Failure: Current Evidence and Future Perspectives. Eur J Heart Fail. Published 8 January 2025. doi:10.
Summarised from the published abstract; every number is checked against it